CFA
ATYR

Carroll Financial Associates’s aTyr Pharma ATYR Stock Holding History

Carroll Financial Associates’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1
Closed – – 1712
2019
Q4 		$0 Hold
1
– – ﹤0.01% 1723
2019
Q3 		$0 Buy
+1
New +$4 ﹤0.01% 1746

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Carroll Financial Associates's ATYR Position: Q1 2020 in Review

Carroll Financial Associates sold out of aTyr Pharma (ATYR) in Q1 2020, closing a stake of 1 share.

Carroll Financial Associates first reported a position in ATYR in Q3 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2019. 24 funds tracked by Wall St. Rank hold ATYR as of Q1 2020.

  • Carroll Financial Associates reported no remaining aTyr Pharma position as of Q1 2020 after selling out during the quarter.
  • Carroll Financial Associates sold 1 aTyr Pharma share in Q1 2020.
  • Carroll Financial Associates first reported a position in aTyr Pharma in Q3 2019 and held it in 2 quarters.
  • Carroll Financial Associates's aTyr Pharma position peaked at $0 in Q4 2019.
  • 24 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2020.

Based on Carroll Financial Associates's 13F filing for Q1 2020, filed 10 Apr 2020.